Search Bar & Filters
Found 14 Actively Recruiting clinical trials
Actively Recruiting
Researchers are evaluating the effectiveness of nipocalimab compared to placebo in adults with moderate to severe systemic lupus erythematosus SLE, a long-term autoimmune disease where the immune system attacks healthy tissues causing inflammation in various organs. This phase 3, randomized, double-blind study aims to determine how well nipocalimab works alongside standard care treatments in managing SLE symptoms and disease activity. Participants will receive either nipocalimab or placebo combined with standard care treatments during a 52-week double-blind period. After this, eligible participants from both groups can join an open-label extension where they will continue to receive nipocalimab until Week 156 or until the study intervention is stopped. This design allows comparison of nipocalimabs effects versus placebo and longer-term safety and effectiveness in an open-label setting. Throughout the study, participants undergo regular assessments including disease activity indexes, joint evaluations, and fatigue scores. Researchers will track the percentage of participants achieving a standard SLE response measure at Week 52 and monitor changes in oral glucocorticoid use, joint pain, and flare-free status. Safety and treatment adherence are closely monitored across study visits, with data collected up to 3 years for long-term evaluation.
Actively Recruiting
Researchers are evaluating two treatment approaches for patients with acute atrial fibrillation or atrial flutter when rhythm control is desired. The study compares conventional acute cardioversion performed within 48 hours in the emergency department to elective delayed cardioversion performed approximately one week later in an out-patient clinic. The goal is to see if these arrhythmias can be safely managed with an elective timing approach. Participants are randomly assigned to either immediate cardioversion in the emergency department or to an elective delayed cardioversion after discharge. All patients receive anticoagulation treatment according to guidelines, with extra precautions such as transesophageal cardiac ultrasound if needed before delayed cardioversion. Patients in the elective group can choose early cardioversion if symptoms become unmanageable before the scheduled out-patient visit. Participants undergo follow-up visits including a cardiologist assessment about one week after enrollment and further assessments one month later with an ECG to check heart rhythm. Quality of life and symptom monitoring occur during the first week and one month after the clinic visit. Patients are then followed up for up to five years to monitor any medical interventions related to atrial fibrillation or flutter. New antiarrhythmic drugs like flecainide are not used during the first month.
Actively Recruiting
Researchers are comparing the safety and effectiveness of laparoscopic cholecystectomy versus a wait-and-see approach in elderly patients who have had successful endoscopic removal of common bile duct stones. The study aims to determine if waiting without immediate surgery is not worse than having the gallbladder removed laparoscopically. The main goal is to observe death, major postoperative complications, or recurrent biliary disease within one year after randomization. Four hundred participants aged 75 or older with cleared bile duct stones are randomly assigned to one of two groups. One group receives laparoscopic cholecystectomy within two weeks after stone removal, while the other group is managed without surgery initially but can have cholecystectomy later if needed. An interim safety analysis is planned after 100 participants to ensure no significant differences arise between groups. The trial may end early if strong evidence shows a difference in outcomes. Participants are followed for up to one year after randomization to track the composite outcome of death, major complications, or biliary events. Researchers also monitor quality of life, survival, healthcare costs, and pain related to biliary issues at various time points. The study includes assessments at 30, 180, and 365 days, with additional monitoring of hospitalizations and complications extending to two years in some measures.
Actively Recruiting
This research focuses on patients undergoing laparoscopic colorectal surgery for various conditions. It aims to evaluate heart rate variability HRV parameters, such as RMSSD, before and after surgery to understand how surgical effects and possible complications impact these measurements and relate to specific adverse outcomes. Participants receive standard colorectal surgery followed by monitoring using the PulseOn device to measure HRV after the operation. The study specifically examines changes in HRV within three days post-surgery to assess recovery and complications. During the study, participants HRV is tracked before and after surgery, with data collected via the PulseOn device. Researchers monitor HRV changes and complications to evaluate recovery quality. The total participation involves preoperative and postoperative assessments focused on physiological monitoring within the first few days after surgery.
Actively Recruiting
This research evaluates the use of drug-coated balloons DCB compared to drug-eluting stents DES in patients with stable coronary artery disease CAD or acute coronary syndrome ACS who are at high risk of bleeding. The study aims to test whether using DCB with a shorter dual antiplatelet therapy DAPT regimen is not worse than using DES with a longer DAPT duration. If the DCB strategy is found not inferior, its superiority over DES will be further assessed. Participants will receive either a DCB or a DES during percutaneous coronary intervention PCI. The DCB group uses the SeQuent Please device combined with a tailored antithrombotic regimen based on patient stability and oral anticoagulation use. The DES group involves implantation of various CE-marked drug-eluting stents alongside individualized antithrombotic treatment. Treatment regimens vary between stable patients and those with ACS, with differences in DAPT duration and lifelong therapies. Throughout the study, participants are monitored for major adverse cardiac events MACE and bleeding episodes using the BARC classification over 12 months as the primary outcome. Additional outcomes include mortality, revascularization events, myocardial infarction, stroke, and bleeding tracked up to 36 months. The study uses a randomized, triple-blind design to compare these treatments with ongoing safety and efficacy assessments.
Actively Recruiting
Researchers are evaluating the use of mobile-device assisted management of hypertension combined with screening for hidden atrial fibrillation in patients who recently experienced an ischemic stroke or transient ischemic attack TIA. The trial aims to compare this approach to standard care in reducing cardiovascular risks. The study focuses on detecting atrial fibrillation, a key treatable risk factor, and improving blood pressure control, both important for preventing recurrent strokes. Participants are randomly assigned in a 21 ratio to either the standard diagnostic work-up and treatment group or an intervention group. The intervention involves 3 weeks of continuous ECG monitoring to detect hidden atrial fibrillation and monthly self-monitoring of blood pressure for one week with self-adjustment of blood pressure medications guided by a mobile device application. The control group receives usual follow-up and hypertension management without these additional technologies. During the 12-month study period, researchers will measure the incidence of new atrial fibrillation cases and changes in average blood pressure. Secondary outcomes include new cardiovascular events and healthcare costs up to 36 months. Participants will undergo regular assessments and follow-up to monitor these outcomes, with safety and adherence tracked throughout the study.
Actively Recruiting
Healthy Volunteer
Endometriosis is a long-lasting condition where tissue similar to the lining inside the uterus grows outside it, causing pain and fertility problems for many women of reproductive age. This research aims to find specific RNA and protein markers in endometriosis tissue and normal uterine lining to help develop new treatments and diagnostic tools. The study also seeks to identify markers that predict disease progression and infertility through a detailed 10-year follow-up. Participants include women aged 19 to 48 years either with surgically confirmed endometriosis or healthy women without endometriosis confirmed by laparoscopy during sterilization. The study involves collecting tissue samples during surgery by laparoscopy or laparotomy for analysis of hormone metabolism and gene expression. Healthy volunteers are also included to provide comparison samples. During the study, researchers will collect samples during surgery and follow participants annually for up to 10 years using questionnaires about pain symptoms, fertility, and treatments. The study measures hormone levels and gene expression in tissues and blood, and tracks pain recurrence after surgery. This long-term follow-up aims to better understand disease behavior and support development of personalized treatment options.
Actively Recruiting
Researchers are investigating whether surgery improves outcomes for adults with painful wrist ganglions compared to conservative care. This study is a multicenter, randomized, controlled trial conducted in Finland and Singapore. It aims to determine if surgery results in better patient-reported pain, function, quality of life, and satisfaction over a 6-month follow-up period. Participants will be randomly assigned to either undergo ganglion resection surgery or receive conservative treatment. Surgery involves either an open or arthroscopic approach performed within two months of assignment, followed by active range of motion exercises and self-implemented hand exercises. The conservative group receives education about the condition, may have needle aspiration if clinically indicated, and performs self-guided exercises three times a week until symptoms improve. Participants will complete questionnaires measuring wrist pain, function, quality of life, and satisfaction at 3, 6, and 12 months. Researchers will also monitor ganglion presence, sick leave duration, and adverse events. The study lasts up to 12 months with primary evaluation at 6 months and includes regular follow-ups to assess recovery and outcomes.
Actively Recruiting
Researchers are evaluating a health psychological group rehabilitation program for patients diagnosed with Chronic Fatigue Syndrome MECFS, a condition marked by long-lasting fatigue, cognitive difficulties, and issues with standing up orthostatic intolerance. The study aims to improve overall functioning and illness management by exploring group therapy effects and comparing treated patients with a control group receiving health counseling. The study includes two groups one receives eight group rehabilitation sessions over four months focusing on stress management, pacing, coping, emotional support, and autonomic nervous system concerns. The control group attends six sessions over three months on health, lifestyle, and wellbeing counseling covering sleep, nutrition, and daily activities. Participants are randomly assigned to either group. Participants will undergo psychological and psychiatric assessments, laboratory tests, and autonomic nervous system antibody measurements before and after the intervention, plus a three-month follow-up. Outcomes include disability and autonomic symptom assessments, anxiety and depression scales, sense of coherence, fatigue severity, and patient health questionnaires. The total study duration includes rehabilitation and follow-up periods, with progress evaluated at multiple time points.
Actively Recruiting
Healthy Volunteer
This research evaluates the effects of nature-based therapies on patients undergoing stroke rehabilitation in a hospital ward. It aims to compare the outcomes of patients receiving additional outdoor therapy sessions with those performing conventional indoor rehabilitation tasks. The study is randomized and controlled, focusing on stroke rehabilitation, and monitors physical, psychological, and microbiological changes during the recovery process. Participants are randomly assigned in a 21 ratio to either an intervention group or a control group. The intervention group attends three therapy sessions per week outdoors, including individual visits with a research worker, group sessions, and sessions with a family member or volunteer. The control group is advised to perform simple indoor rehabilitation activities. Blood and microbiome samples are collected before the interventions and again after 4 weeks and 3 months post-discharge. Throughout the study, questionnaires assessing mood, quality of life, and functional deficits are administered at baseline, after 4 weeks, and 3 months after discharge. Physiological measures evaluate autonomic nerve function. The study also tracks mood and quality of life changes in participating family members. Primary outcomes focus on functional ability within 30 days, while secondary outcomes assess quality of life, rehabilitation impact, psychological effects, microbiome changes, and autonomic nervous system activity over up to 120 days.
1-10 of 14
1